Compositions comprising balaglitazone and further antidiabetic compounds

摘要

Methods for treating conditions benefiting from a decrease in insulin resistance, a reduction of plasma glucose levels, a reduction of plasma fatty acid levels, a reduction of plasma triglyceride levels or reduction of VLDL levels comprising the administration of a composition consisting essentially of balaglitazone in combination with one or more dipeptidyl peptidase-IV inhibitors to a patient in need thereof.